{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:51:58Z","timestamp":1784127118132,"version":"3.55.0"},"reference-count":147,"publisher":"Elsevier","isbn-type":[{"value":"9780443431708","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.vh.2025.08.002","type":"book-chapter","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T20:23:39Z","timestamp":1767039819000},"page":"69-104","source":"Crossref","is-referenced-by-count":2,"title":["Clinical manifestations of primary aldosteronism and cardiometabolic risk"],"prefix":"10.1016","author":[{"given":"Eider","family":"Pascual-Corrales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"Ruiz-C\u00e1novas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Mar\u00eda P\u00e9rez","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/bs.vh.2025.08.002_bib0001","doi-asserted-by":"crossref","first-page":"673","DOI":"10.7326\/M17-2237","article-title":"Subclinical primary aldosteronism","volume":"167","author":"Adlin","year":"2017","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.002_bib0002","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s12020-016-0983-9","article-title":"Worsening of lipid metabolism after successful treatment of primary aldosteronism","volume":"54","author":"Adolf","year":"2020","journal-title":"Endocrine"},{"issue":"9","key":"10.1016\/bs.vh.2025.08.002_bib0003","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1210\/jc.2011-0138","article-title":"Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and\/or amiloride, including a comparison with our previously published results in those with unilateral disease treated surgically","volume":"96","author":"Ahmed","year":"2011","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.002_bib0004","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3109\/15622975.2012.665480","article-title":"Gender differences in anxiety and depressive symptoms in patients with primary hyperaldosteronism: a cross-sectional study","volume":"15","author":"Apostolopoulou","year":"2014","journal-title":"World Journal of Biological Psychiatry"},{"key":"10.1016\/bs.vh.2025.08.002_bib0005","doi-asserted-by":"crossref","unstructured":"Araujo-Castro, M., Paja Fano, M., Gonz\u00e1lez-Boillos, M., Pascual-Corrales, E., Mart\u00edn Rojas-Marcos, P., Garc\u00eda-Cano, A., ..., Parra Ram\u00edrez, P. (2024). Impact of primary aldosteronism on kidney function: results from the SPAIN-ALDO registry. J Hypertens. 42(10) 1805\u20131812.","DOI":"10.1097\/HJH.0000000000003813"},{"issue":"3","key":"10.1016\/bs.vh.2025.08.002_bib0006","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s12020-022-03029-4","article-title":"Evolution of the cardiometabolic profile of primary hyperaldosteronism patients treated with adrenalectomy and with mineralocorticoid receptor antagonists: results from the SPAIN-ALDO Registry","volume":"76","author":"Araujo-Castro","year":"2022","journal-title":"Endocrine"},{"issue":"9","key":"10.1016\/bs.vh.2025.08.002_bib0008","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.medcli.2021.10.012","article-title":"Diagnosis of primary hyperaldosteronism","volume":"158","author":"Araujo-Castro","year":"2022","journal-title":"Medicina Cl\u00ednica"},{"issue":"11","key":"10.1016\/bs.vh.2025.08.002_bib0007","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1007\/s40618-023-02090-8","article-title":"Prevalence, risk factors and evolution of diabetes mellitus after treatment in primary aldosteronism. Results from the SPAIN-ALDO registry","volume":"46","author":"Araujo-Castro","year":"2023","journal-title":"Journal of Endocrinological Investigation"},{"issue":"8","key":"10.1016\/bs.vh.2025.08.002_bib0009","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.endinu.2024.05.007","article-title":"Executive summary of the Spanish consensus for the diagnosis, management, and follow-up of primary hyperaldosteronism","volume":"71","author":"Araujo-Castro","year":"2024","journal-title":"Endocrinol Diabetes Nutricion (Engl Ed)"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.002_bib0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12020-024-03751-1","volume":"85","author":"Araujo-Castro","year":"2024","journal-title":"Endocrine"},{"issue":"761","key":"10.1016\/bs.vh.2025.08.002_bib0011","first-page":"537","article-title":"Primary hyperaldosteronism and depression","volume":"97","author":"Avery","year":"1984","journal-title":"The New Zealand Medical Journal"},{"issue":"5","key":"10.1016\/bs.vh.2025.08.002_bib0012","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/HYPERTENSIONAHA.116.08952","article-title":"Continuum of renin-independent aldosteronism in normotension","volume":"69","author":"Baudrand","year":"2017","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.002_bib0013","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/HYPERTENSIONAHA.114.04488","article-title":"Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases","volume":"65","author":"Bauersachs","year":"2015","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.002_bib0014","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/cen.13891","article-title":"Primary aldosteronism is associated with decreased low-density and high-density lipoprotein particle concentrations and increased GlycA, a pro-inflammatory glycoprotein biomarker","volume":"90","author":"Berends","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"10.1016\/bs.vh.2025.08.002_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23094803","article-title":"Primary aldosteronism and resistant hypertension: A pathophysiological insight","volume":"23","author":"Bioletto","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"9","key":"10.1016\/bs.vh.2025.08.002_bib0016","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/M17-0882","article-title":"The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension: A Cohort Study","volume":"167","author":"Brown","year":"2017","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.002_bib0017","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study","volume":"173","author":"Brown","year":"2020","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.002_bib0018","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/HYPERTENSIONAHA.107.095489","article-title":"Aldosterone and vascular inflammation","volume":"51","author":"Brown","year":"2008","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/bs.vh.2025.08.002_bib0019","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13419","article-title":"Quality of life in primary aldosteronism: A prospective observational study","volume":"51","author":"Buffolo","year":"2021","journal-title":"European Journal of Clinical Investigation"},{"issue":"6","key":"10.1016\/bs.vh.2025.08.002_bib0020","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1161\/HYPERTENSIONAHA.119.13833","article-title":"Primary Aldosteronism and Obstructive Sleep Apnea: A Cross-Sectional Multi-Ethnic Study","volume":"74","author":"Buffolo","year":"2019","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/bs.vh.2025.08.002_bib0021","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1055\/s-0043-119755","article-title":"Is primary aldosteronism still largely unrecognized?","volume":"49","author":"Buffolo","year":"2017","journal-title":"Hormone and Metabolic Research"},{"issue":"9","key":"10.1016\/bs.vh.2025.08.002_bib0022","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/HYPERTENSIONAHA.122.17964","article-title":"Aldosterone as a mediator of cardiovascular damage","volume":"79","author":"Buffolo","year":"2022","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.002_bib0023","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/HYPERTENSIONAHA.119.13772","article-title":"Renin-angiotensin-aldosterone system triple-a analysis for the screening of primary aldosteronism","volume":"75","author":"Burrello","year":"2020","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/bs.vh.2025.08.002_bib0024","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/HYPERTENSIONAHA.119.14063","article-title":"Prevalence of hypokalemia and primary aldosteronism in 5100 patients referred to a tertiary hypertension unit","volume":"75","author":"Burrello","year":"2020","journal-title":"Hypertension."},{"issue":"8","key":"10.1016\/bs.vh.2025.08.002_bib0025","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.118.033597","article-title":"Primary aldosteronism: Practical approach to diagnosis and management","volume":"138","author":"Byrd","year":"2018","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/bs.vh.2025.08.002_bib0026","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"issue":"Suppl 1","key":"10.1016\/bs.vh.2025.08.002_bib0027","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000178029","article-title":"Primary aldosteronism","volume":"71","author":"Carey","year":"2009","journal-title":"Hormone Research in Paediatrics"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.002_bib0028","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11906-008-0019-9","article-title":"Local adipose tissue renin-angiotensin system","volume":"10","author":"Cassis","year":"2008","journal-title":"Current Hypertension Reports"},{"issue":"6","key":"10.1016\/bs.vh.2025.08.002_bib0029","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/HYPERTENSIONAHA.120.16902","article-title":"Prospective screening for primary aldosteronism in patients with suspected obstructive sleep apnea","volume":"77","author":"Chee","year":"2021","journal-title":"Hypertension"},{"issue":"20","key":"10.1016\/bs.vh.2025.08.002_bib0030","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.3390\/ijms20205214","article-title":"TAIPAI Study Group. Endothelial dysfunction in primary aldosteronism","volume":"20","author":"Chen","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.vh.2025.08.002_bib0031","series-title":"StatPearls [Internet]","article-title":"Primary hyperaldosteronism","author":"Cobb","year":"2025"},{"issue":"4","key":"10.1016\/bs.vh.2025.08.002_bib0032","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1053\/j.ajkd.2021.12.016","article-title":"Metabolic alkalosis pathogenesis, diagnosis, and treatment: Core curriculum 2022","volume":"80","author":"Do","year":"2022","journal-title":"American Journal of Kidney Diseases"},{"issue":"9628","key":"10.1016\/bs.vh.2025.08.002_bib0033","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","article-title":"Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study","volume":"371","author":"Douma","year":"2008","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.002_bib0034","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3390\/ijms25020900","article-title":"What We Know about and What Is New in Primary Aldosteronism","volume":"25","author":"Ekman","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.1016\/bs.vh.2025.08.002_bib0035","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1681\/ASN.2015070751","article-title":"Potassium and its discontents: New insight, new treatments","volume":"27","author":"Ellison","year":"2016","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.002_bib0036","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s001090000144","article-title":"The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension","volume":"79","author":"Engeli","year":"2001","journal-title":"Journal of Molecular Medicine"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.002_bib0037","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1210\/jc.2005-1733","article-title":"Prevalence and characteristics of the metabolic syndrome in primary aldosteronism","volume":"91","author":"Fallo","year":"2006","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"6","key":"10.1016\/bs.vh.2025.08.002_bib0038","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/HYPERTENSIONAHA.110.154427","article-title":"Relationship between overnight rostral fluid shift and obstructive sleep apnea in drug-resistant hypertension","volume":"56","author":"Friedman","year":"2010","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/bs.vh.2025.08.002_bib0039","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"Funder","year":"2016","journal-title":"The Journal of Clinical Endocrinology & Metabolism."},{"issue":"4","key":"10.1016\/bs.vh.2025.08.002_bib0040","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5664\/jcsm.27878","article-title":"Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension","volume":"6","author":"Gonzaga","year":"2010","journal-title":"Journal of Clinical Sleep Medicine"},{"issue":"5-6","key":"10.1016\/bs.vh.2025.08.002_bib0041","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0952-3278(99)80020-9","article-title":"Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans","volume":"60","author":"Goodfriend","year":"1999","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"13","key":"10.1016\/bs.vh.2025.08.002_bib0042","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/CIRCULATIONAHA.124.073507","article-title":"Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study","volume":"152","author":"Goupil","year":"2025","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/bs.vh.2025.08.002_bib0043","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0025-6196(12)61380-9","article-title":"Adjustment of the osmostat in primary aldosteronism","volume":"69","author":"Gregoire","year":"1994","journal-title":"Mayo Clinic Proceedings"},{"issue":"18","key":"10.1016\/bs.vh.2025.08.002_bib0044","first-page":"1787","article-title":"An integrated view of potassium homeostasis","volume":"373","author":"Gumz","year":"2015","journal-title":"The New England Journal of Medicine"},{"issue":"17","key":"10.1016\/bs.vh.2025.08.002_bib0045","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","article-title":"Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines","volume":"117","author":"Guo","year":"2008","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/bs.vh.2025.08.002_bib0046","doi-asserted-by":"crossref","first-page":"e1574","DOI":"10.1210\/clinem\/dgad752","article-title":"Prolonged hypokalemia and delayed diagnosis of primary aldosteronism: clinical course and risk factors","volume":"109","author":"Gupta","year":"2024","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"11","key":"10.1016\/bs.vh.2025.08.002_bib0047","first-page":"716","article-title":"Primary aldosteronism - why is it still underdiagnosed in clinical practice?]","volume":"145","author":"Handgriff","year":"2020","journal-title":"Deutsche Medizinische Wochenschrift"},{"key":"10.1016\/bs.vh.2025.08.002_bib0048","doi-asserted-by":"crossref","first-page":"4128174","DOI":"10.1155\/2018\/4128174","article-title":"Physiological aldosterone concentrations are associated with alterations of lipid metabolism: Observations from the general population","volume":"2018","author":"Hannich","year":"2018","journal-title":"International Journal of Endocrinology"},{"issue":"5","key":"10.1016\/bs.vh.2025.08.002_bib0049","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1530\/EJE-15-0450","article-title":"Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry","volume":"173","author":"Hanslik","year":"2015","journal-title":"European Journal of Endocrinology"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.002_bib0050","doi-asserted-by":"crossref","first-page":"e809","DOI":"10.1210\/clinem\/dgad516","article-title":"Approach to the Patient: Reninoma","volume":"109","author":"Hayes","year":"2024","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"5","key":"10.1016\/bs.vh.2025.08.002_bib0051","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrneph.2012.19","article-title":"Glomerular hyperfiltration: definitions, mechanisms and clinical implications","volume":"8","author":"Helal","year":"2012","journal-title":"Nature Reviews Nephrology"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.002_bib0052","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/cvr\/cvp191","article-title":"Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice","volume":"84","author":"Hirata","year":"2009","journal-title":"Cardiovascular Research"},{"issue":"29","key":"10.1016\/bs.vh.2025.08.002_bib0054","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000020826","article-title":"Normotensive hypokalemic primary hyperaldosteronism mimicking clinical features of anorexia nervosa in a young patient: A case report","volume":"99","author":"Huang","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.002_bib0055","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.123.066389","article-title":"Subclinical primary aldosteronism and cardiovascular health: A population-based cohort study","volume":"149","author":"Hundemer","year":"2024","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/bs.vh.2025.08.002_bib0056","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/HYPERTENSIONAHA.118.11568","article-title":"Renal outcomes in medically and surgically treated primary aldosteronism","volume":"72","author":"Hundemer","year":"2018","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/bs.vh.2025.08.002_bib0057","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s40618-025-02563-y","article-title":"Impact of primary aldosteronism on calcium phosphate homeostasis. Results from the SPAIN-ALDO","volume":"48","author":"Iriarte-Dur\u00e1n","year":"2025","journal-title":"Journal of Endocrinological Investigation"},{"issue":"4","key":"10.1016\/bs.vh.2025.08.002_bib0058","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.beem.2011.11.006","article-title":"Subclinical primary aldosteronism","volume":"26","author":"Ito","year":"2012","journal-title":"Best Practice & Research Clinical Endocrinology"},{"issue":"6","key":"10.1016\/bs.vh.2025.08.002_bib0059","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/01.RES.0000159937.05502.d1","article-title":"Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells","volume":"96","author":"Jaffe","year":"2005","journal-title":"Circulation Research"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.002_bib0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1124\/pr.115.011106","article-title":"Emerging roles of the mineralocorticoid receptor in pathology: Toward new paradigms in clinical pharmacology","volume":"68","author":"Jaisser","year":"2016","journal-title":"Pharmacological Reviews"},{"issue":"12","key":"10.1016\/bs.vh.2025.08.002_bib0061","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1007\/s00268-015-3197-z","article-title":"Risk of new-onset dyslipidemia after laparoscopic adrenalectomy in patients with primary aldosteronism","volume":"39","author":"Kaga","year":"2015","journal-title":"World Journal of Surgery"},{"issue":"667","key":"10.1016\/bs.vh.2025.08.002_bib0062","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.3399\/bjgp18X694589","article-title":"Prevalence of primary aldosteronism in primary care: a cross-sectional study","volume":"68","author":"Kayser","year":"2018","journal-title":"British Journal of General Practice"},{"issue":"7","key":"10.1016\/bs.vh.2025.08.002_bib0063","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis","volume":"101","author":"K\u00e4yser","year":"2016","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/bs.vh.2025.08.002_bib0064","doi-asserted-by":"crossref","first-page":"45241","DOI":"10.1038\/srep45241","article-title":"Association of aldosterone excess and apnea-hypopnea index in patients with resistant hypertension","volume":"7","author":"Ke","year":"2017","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.002_bib0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/kidneydial5010003","article-title":"Renal dysfunction in primary aldosteronism: how, when, and who?","volume":"5","author":"Kitlinski","year":"2025","journal-title":"Kidney and Dialysis"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.002_bib0066","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/a-1556-7784","article-title":"Autonomous aldosterone secretion as a subclinical form of primary aldosteronism: Pathogenesis and clinical significance","volume":"130","author":"Kmiec","year":"2022","journal-title":"Experimental and Clinical Endocrinology & Diabetes"},{"issue":"3","key":"10.1016\/bs.vh.2025.08.002_bib0067","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/HYPERTENSIONAHA.119.13131","article-title":"Association between acute Fall in estimated glomerular filtration rate after treatment for primary aldosteronism and long-term decline in renal function","volume":"74","author":"Kobayashi","year":"2019","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/bs.vh.2025.08.002_bib0068","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1055\/s-0032-1301921","article-title":"Psychopathological symptoms in patients with primary hyperaldosteronism\u2013possible pathways","volume":"44","author":"Kunzel","year":"2012","journal-title":"Hormone and Metabolic Research"},{"issue":"5","key":"10.1016\/bs.vh.2025.08.002_bib0069","first-page":"1357","article-title":"Increased adrenal medullary atrial natriuretic polypeptide synthesis in patients with primary aldosteronism","volume":"76","author":"Lee","year":"1993","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.002_bib0070","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm1545","article-title":"Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity","volume":"13","author":"Leopold","year":"2007","journal-title":"Natural Medicines"},{"issue":"7","key":"10.1016\/bs.vh.2025.08.002_bib0071","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/jch.14794","article-title":"Target organ damage in untreated hypertensive patients with primary aldosteronism","volume":"26","author":"Li","year":"2024","journal-title":"The Journal of Clinical Hypertension"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.002_bib0072","doi-asserted-by":"crossref","first-page":"8755","DOI":"10.1038\/s41598-025-92477-9","article-title":"The association between aldosterone and lipid profiles in patients with primary aldosteronism","volume":"15","author":"Liang","year":"2025","journal-title":"Scientific Reports"},{"issue":"6","key":"10.1016\/bs.vh.2025.08.002_bib0073","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1161\/CIRCOUTCOMES.115.002002","article-title":"Cost-effectiveness of screening for primary aldosteronism and subtype diagnosis in the resistant hypertensive patients","volume":"8","author":"Lubitz","year":"2015","journal-title":"Circulation Cardiovascular Quality and Outcomes"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.002_bib0074","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12902-022-01135-y","article-title":"The differences of serum lipid profiles between primary aldosteronism and essential hypertension: A meta-analysis and systematic review","volume":"22","author":"Manosroi","year":"2022","journal-title":"BMC Endocrine Disorders"},{"key":"10.1016\/bs.vh.2025.08.002_bib0075","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mam.2016.04.001","article-title":"Once and for all, LXRalpha and LXRbeta are gatekeepers of the endocrine system","volume":"49","author":"Maqdasy","year":"2016","journal-title":"Molecular Aspects of Medicine"},{"issue":"4","key":"10.1016\/bs.vh.2025.08.002_bib0076","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1210\/jc.2012-3353","article-title":"Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension","volume":"98","author":"Markou","year":"2013","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"4","key":"10.1016\/bs.vh.2025.08.002_bib0077","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/HYPERTENSIONAHA.108.122002","article-title":"Fasting plasma glucose and serum lipids in patients with primary aldosteronism: A controlled cross-sectional study","volume":"53","author":"Matrozova","year":"2009","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/bs.vh.2025.08.002_bib0078","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ncpneph0151","article-title":"Primary aldosteronism: diagnostic and treatment strategies","volume":"2","author":"Mattsson","year":"2006","journal-title":"Nature Clinical Practice Nephrology"},{"issue":"8","key":"10.1016\/bs.vh.2025.08.002_bib0079","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"Journal of the American College of Cardiology"},{"issue":"14","key":"10.1016\/bs.vh.2025.08.002_bib0080","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.002_bib0081","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"10.1016\/bs.vh.2025.08.002_bib0082","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/cen.13741","article-title":"Diagnostic approach to low-renin hypertension","volume":"89","author":"Monticone","year":"2018","journal-title":"Clinical Endocrinology (Oxf)"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.002_bib0083","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0000000000002216","article-title":"Renal damage in primary aldosteronism: a systematic review and meta-analysis","volume":"38","author":"Monticone","year":"2020","journal-title":"Journal of Hypertension"},{"issue":"4","key":"10.1016\/bs.vh.2025.08.002_bib0084","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3803\/EnM.2021.1012","article-title":"Lipid profiles in primary aldosteronism compared with essential hypertension: Propensity-score matching study","volume":"36","author":"Moon","year":"2021","journal-title":"Endocrinology and Metabolism"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.002_bib0085","first-page":"156","article-title":"A woman with normotensive primary hyperaldosteronism","volume":"54","author":"Moradi","year":"2016","journal-title":"Acta Medica Iranica"},{"issue":"3","key":"10.1016\/bs.vh.2025.08.002_bib0086","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"8","key":"10.1016\/bs.vh.2025.08.002_bib0087","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1507\/endocrj.EJ13-0060","article-title":"Prevalence and clinical characteristics of primary aldosteronism in Japanese patients with type 2 diabetes mellitus and hypertension","volume":"60","author":"Murase","year":"2013","journal-title":"Endocrine Journal"},{"issue":"6","key":"10.1016\/bs.vh.2025.08.002_bib0088","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/cen.14434","article-title":"Association between plasma aldosterone and markers of tubular and glomerular damage in primary aldosteronism","volume":"94","author":"Nakamura","year":"2021","journal-title":"Clinical Endocrinology (Oxf)"},{"issue":"4","key":"10.1016\/bs.vh.2025.08.002_bib0089","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.HYP.0000258554.87444.91","article-title":"Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample","volume":"49","author":"Newton-Cheh","year":"2007","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.002_bib0090","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/HYPERTENSIONAHA.121.17436","article-title":"Renal injuries in primary aldosteronism: Quantitative histopathological analysis of 19 patients with primary adosteronism","volume":"78","author":"Ogata","year":"2021","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/bs.vh.2025.08.002_bib0091","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/ajh\/5.11.811","article-title":"Usefulness of atrial natriuretic peptide assay in primary aldosteronism","volume":"5","author":"Opocher","year":"1992","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/bs.vh.2025.08.002_bib0093","series-title":"Endotext","article-title":"Hyperaldosteronism","author":"Papadopoulou-Marketou","year":"2000"},{"issue":"11","key":"10.1016\/bs.vh.2025.08.002_bib0094","doi-asserted-by":"crossref","first-page":"e3832","DOI":"10.1210\/clinem\/dgaf129","article-title":"Subclinical primary aldosteronism Is characterized by maladaptive natriuretic peptide and adrenal hormonal physiology","volume":"110","author":"Parisien-La Salle","year":"2025","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"6","key":"10.1016\/bs.vh.2025.08.002_bib0095","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1055\/a-1133-7255","article-title":"Primary aldosteronism and obstructive sleep apnea: Casual association or pathophysiological link?","volume":"52","author":"Pecori","year":"2020","journal-title":"Hormone and Metabolic Research"},{"issue":"6","key":"10.1016\/bs.vh.2025.08.002_bib0096","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/ki.1996.258","article-title":"Aldosterone and potassium homeostasis","volume":"49","author":"Rabinowitz","year":"1996","journal-title":"Kidney International"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.002_bib0097","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jphs.10R07CR","article-title":"Pathophysiological roles of aldosterone and mineralocorticoid receptor in the kidney","volume":"115","author":"Rafiq","year":"2011","journal-title":"Journal of Pharmacological Sciences"},{"issue":"12","key":"10.1016\/bs.vh.2025.08.002_bib0098","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","article-title":"Diagnosis and treatment of primary aldosteronism","volume":"9","author":"Reincke","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/bs.vh.2025.08.002_bib0099","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1210\/jc.2008-1851","article-title":"Participants of German Conn\u2019s Registry. Risk factors associated with a low glomerular filtration rate in primary aldosteronism","volume":"94","author":"Reincke","year":"2009","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"5","key":"10.1016\/bs.vh.2025.08.002_bib0100","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1681\/ASN.2004100878","article-title":"Relative glomerular hyperfiltration in primary aldosteronism","volume":"16","author":"Ribstein","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1016\/bs.vh.2025.08.002_bib0101","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s40620-019-00684-1","article-title":"Recent insights into sodium and potassium handling by the aldosterone-sensitive distal nephron: A review of the relevant physiology","volume":"33","author":"Rossi","year":"2020","journal-title":"Journal of Nephrology"},{"issue":"7","key":"10.1016\/bs.vh.2025.08.002_bib0102","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1210\/jc.2008-0251","article-title":"Primary aldosteronism prevalence in hypertension study investigators. Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients","volume":"93","author":"Rossi","year":"2008","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"11","key":"10.1016\/bs.vh.2025.08.002_bib0103","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.002_bib0104","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","article-title":"PAPY study participants. renal damage in primary aldosteronism: results of the PAPY Study","volume":"48","author":"Rossi","year":"2006","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/bs.vh.2025.08.002_bib0105","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1161\/HYPERTENSIONAHA.124.22642","article-title":"Clinical management of primary aldosteronism: An update","volume":"81","author":"Rossi","year":"2024","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/bs.vh.2025.08.002_bib0106","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/01.HYP.27.5.1039","article-title":"Changes in left ventricular anatomy and function in hypertension and primary aldosteronism","volume":"27","author":"Rossi","year":"1996","journal-title":"Hypertension"},{"issue":"22","key":"10.1016\/bs.vh.2025.08.002_bib0107","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1016\/j.jacc.2019.09.057","article-title":"Primary aldosteronism: JACC state-of-the-art review","volume":"74","author":"Rossi","year":"2019","journal-title":"Journal of the American College of Cardiology"},{"issue":"11","key":"10.1016\/bs.vh.2025.08.002_bib0109","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1097\/HJH.0000000000002924","article-title":"Japan Primary Aldosteronism Study\/Japan Rare Intractable Adrenal Diseases Study Group. Subtype-specific trends in the clinical picture of primary aldosteronism over a 13-year period","volume":"39","author":"Saito","year":"2021","journal-title":"Journal of Hypertension"},{"issue":"11","key":"10.1016\/bs.vh.2025.08.002_bib0110","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1055\/s-0035-1559645","article-title":"Cost-Effectiveness Analysis of the Diagnosis and Treatment of Primary Aldosteronism in Japan","volume":"47","author":"Sato","year":"2015","journal-title":"Hormone and Metabolic Research"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.002_bib0111","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: A controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"issue":"22","key":"10.1016\/bs.vh.2025.08.002_bib0112","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","article-title":"Long-term renal outcomes in patients with primary aldosteronism","volume":"295","author":"Sechi","year":"2006","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/bs.vh.2025.08.002_bib0113","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1210\/clinem\/dgae415","article-title":"The prevalence of obstructive sleep apnea in patients with primary aldosteronism","volume":"109","author":"Sheu","year":"2024","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/bs.vh.2025.08.002_bib0114","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.574151","article-title":"Primary aldosteronism and bone metabolism: a systematic review and meta-analysis","volume":"11","author":"Shi","year":"2020","journal-title":"Frontiers in Endocrinology"},{"issue":"3","key":"10.1016\/bs.vh.2025.08.002_bib0115","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1161\/01.HYP.29.3.723","article-title":"Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism","volume":"29","author":"Shigematsu","year":"1997","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/bs.vh.2025.08.002_bib0116","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000093956","article-title":"Psychological aspects of primary aldosteronism","volume":"75","author":"Sonino","year":"2006","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"6","key":"10.1016\/bs.vh.2025.08.002_bib0117","doi-asserted-by":"crossref","first-page":"E878","DOI":"10.1210\/jc.2010-2723","article-title":"Psychological assessment of primary aldosteronism: a controlled study","volume":"96","author":"Sonino","year":"2011","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1016\/bs.vh.2025.08.002_bib0118","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1530\/EJE-22-0040","article-title":"The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex - a multicenter-study of 3566 Caucasian and Asian subjects","volume":"187","author":"Spyroglou","year":"2022","journal-title":"European Journal of Endocrinology"},{"issue":"11","key":"10.1016\/bs.vh.2025.08.002_bib0119","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/00004872-200311000-00025","article-title":"High rate of detection of primary aldosteronism, including surgically treatable forms, after \u201cnon-selective\u201d screening of hypertensive patients","volume":"21","author":"Stowasser","year":"2003","journal-title":"Journal of Hypertension"},{"issue":"4","key":"10.1016\/bs.vh.2025.08.002_bib0120","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1152\/physrev.00026.2015","article-title":"Primary aldosteronism: Changing definitions and new concepts of physiology and pathophysiology both inside and outside the kidney","volume":"96","author":"Stowasser","year":"2016","journal-title":"Physiological Reviews"},{"issue":"9","key":"10.1016\/bs.vh.2025.08.002_bib0121","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2005-0681","article-title":"Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I","volume":"90","author":"Stowasser","year":"2005","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"3","key":"10.1016\/bs.vh.2025.08.002_bib0122","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2009-1763","article-title":"Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism","volume":"95","author":"Sukor","year":"2010","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"8","key":"10.1016\/bs.vh.2025.08.002_bib0123","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1530\/EC-21-0125","article-title":"Improvement in quality of life and psychological symptoms after treatment for primary aldosteronism: Asian Cohort Study","volume":"10","author":"Tan","year":"2021","journal-title":"Endocrine Connections"},{"issue":"2","key":"10.1016\/bs.vh.2025.08.002_bib0124","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1291\/hypres.20.85","article-title":"Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension","volume":"20","author":"Tanabe","year":"1997","journal-title":"Hypertension Research"},{"issue":"6","key":"10.1016\/bs.vh.2025.08.002_bib0125","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/HYPERTENSIONAHA.125.24711","article-title":"ACE inhibition to distinguish low-renin hypertension from primary aldosteronism","volume":"82","author":"Tsai","year":"2025","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/bs.vh.2025.08.002_bib0126","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.numecd.2013.09.009","article-title":"Primary aldosteronism and essential hypertension: Assessment of cardiovascular risk at diagnosis and after treatment","volume":"24","author":"Turchi","year":"2014","journal-title":"Nutrition, Metabolism and Cardiovascular Diseases."},{"issue":"11","key":"10.1016\/bs.vh.2025.08.002_bib0127","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41574-022-00730-2","article-title":"Primary aldosteronism - a multidimensional syndrome","volume":"18","author":"Turcu","year":"2022","journal-title":"Nature Reviews Endocrinology"},{"issue":"12","key":"10.1016\/bs.vh.2025.08.002_bib0128","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1210\/clinem\/dgaa606","article-title":"Evolution of the primary aldosteronism syndrome: Updating the approach","volume":"105","author":"Vaidya","year":"2020","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"6","key":"10.1016\/bs.vh.2025.08.002_bib0129","first-page":"1057","article-title":"The expanding spectrum of primary aldosteronism: Implications for diagnosis","volume":"39","author":"Vaidya","year":"2018","journal-title":"Pathogenesis and Treatment of Primary Aldosteronism."},{"issue":"3","key":"10.1016\/bs.vh.2025.08.002_bib0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11906-018-0819-5","article-title":"Role of mineralocorticoid receptors in obstructive sleep apnea and metabolic syndrome","volume":"20","author":"Valaiyapathi","year":"2018","journal-title":"Current Hypertension Reports"},{"issue":"3","key":"10.1016\/bs.vh.2025.08.002_bib0131","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1530\/eje.0.1410279","article-title":"Aldosterone-producing adenoma without hypertension: a report of two cases","volume":"141","author":"Vantyghem","year":"1999","journal-title":"European Journal of Endocrinology"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.002_bib0132","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa033263","article-title":"Serum aldosterone and the incidence of hypertension in nonhypertensive persons","volume":"351","author":"Vasan","year":"2004","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.002_bib0133","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jc.2017-01442","article-title":"SPARTACUS investigators. Quality of Life in Primary Aldosteronism: A Comparative Effectiveness Study of Adrenalectomy and Medical Treatment.The","volume":"103","author":"Velema","year":"2018","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"12","key":"10.1016\/bs.vh.2025.08.002_bib0134","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1055\/s-0043-121706","article-title":"Health-Related Quality of Life and Mental Health in Primary Aldosteronism: A Systematic Review","volume":"49","author":"Velema","year":"2017","journal-title":"Hormone and Metabolic Research"},{"issue":"7","key":"10.1016\/bs.vh.2025.08.002_bib0135","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1055\/a-1507-5226","article-title":"Prevalence of primary aldosteronism across the stages of hypertension based on a new combined overnight test","volume":"53","author":"Voulgaris","year":"2021","journal-title":"Hormone and Metabolic Research"},{"key":"10.1016\/bs.vh.2025.08.002_bib0136","article-title":"Bone and mineral metabolism in patients with primary aldosteronism: A systematic review and meta-analysis","volume":"13","author":"Wang","year":"2022","journal-title":"Frontiers in Endocrinology"},{"issue":"3","key":"10.1016\/bs.vh.2025.08.002_bib0137","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.semnephrol.2013.04.007","article-title":"Endocrine and hypertensive disorders of potassium regulation: Primary aldosteronism","volume":"33","author":"Weiner","year":"2013","journal-title":"Seminars in Nephrology"},{"issue":"6","key":"10.1016\/bs.vh.2025.08.002_bib0139","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1210\/jc.2003-030490","article-title":"50th anniversary of aldosterone","volume":"88","author":"Williams","year":"2003","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.002_bib0140","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tem.2021.10.002","article-title":"Pathophysiology and histopathology of primary aldosteronism","volume":"33","author":"Williams","year":"2022","journal-title":"Trends in Endocrinology & Metabolism"},{"issue":"8","key":"10.1016\/bs.vh.2025.08.002_bib0141","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1097\/HJH.0000000000001361","article-title":"Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years","volume":"35","author":"Wu","year":"2017","journal-title":"Journal of Hypertension"},{"issue":"26","key":"10.1016\/bs.vh.2025.08.002_bib0142","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015985","article-title":"Cardiovascular risk in primary aldosteronism: A systematic review and meta-analysis","volume":"98","author":"Wu","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/bs.vh.2025.08.002_bib0143","first-page":"1227","article-title":"Metabolic outcomes of primary aldosteronism patients receiving adrenalectomy or spironolactone treatments]","volume":"54","author":"Xu","year":"2023","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"issue":"6","key":"10.1016\/bs.vh.2025.08.002_bib0144","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/en.2003-0279","article-title":"Minireview: primary aldosteronism\u2013changing concepts in diagnosis and treatment","volume":"144","author":"Young","year":"2003","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/bs.vh.2025.08.002_bib0145","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","article-title":"Primary aldosteronism: Renaissance of a syndrome","volume":"66","author":"Young","year":"2007","journal-title":"Clinical Endocrinology"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.002_bib0146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.15.S1.1","volume":"15","author":"Zeiger","year":"2009","journal-title":"Endocrine Practice"},{"key":"10.1016\/bs.vh.2025.08.002_bib0147","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.sleep.2023.12.007","article-title":"Primary aldosteronism and obstructive sleep apnea: A meta-analysis of prevalence and metabolic characteristics","volume":"114","author":"Zhang","year":"2024","journal-title":"Sleep Medication"},{"key":"10.1016\/bs.vh.2025.08.002_bib0138","doi-asserted-by":"crossref","unstructured":"Whelton P.K., Carey R.M., Aronow W.S., Casey D.E. Jr, Collins K.J., Dennison Himmelfarb C., ..., Wright J.T. Jr. 2017 (2018). ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 71(6), e13\u2013e115.","DOI":"10.1161\/HYP.0000000000000076"},{"issue":"1","key":"10.1016\/bs.vh.2025.08.002_bib0108","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1210\/clinem\/dgad400","article-title":"Effect of Obesity on Clinical Characteristics of Primary Aldosteronism Patients at Diagnosis and Postsurgical Response","volume":"109","author":"Ruiz-S\u00e1nchez","year":"2023","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"6","key":"10.1016\/bs.vh.2025.08.002_bib0092","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.3390\/ijms24065370","article-title":"The effect of aldosterone on cardiorenal and metabolic systems","volume":"24","author":"Otsuka","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.1016\/bs.vh.2025.08.002_bib0053","doi-asserted-by":"crossref","first-page":"dgz293","DOI":"10.1210\/clinem\/dgz293","article-title":"Determining the prevalence of primary aldosteronism in patients with new-onset type 2 diabetes and hypertension","volume":"105","author":"Hu","year":"2020","journal-title":"The Journal of Clinical Endocrinology & Metabolism"}],"container-title":["Vitamins and Hormones","Primary Aldosteronism: Physiopathology and Diagnosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672925000457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672925000457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T17:07:30Z","timestamp":1770052050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0083672925000457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443431708"],"references-count":147,"URL":"https:\/\/doi.org\/10.1016\/bs.vh.2025.08.002","relation":{},"ISSN":["0083-6729"],"issn-type":[{"value":"0083-6729","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}